Management of fibromyalgia syndrome

JAMA

Volumn 292, Issue 19, 2004, Pages 2388-2395

  Goldenberg, Don L ^a,b   Burckhardt, Carol ^c   Crofford, Leslie ^d  

^a NEWTON WELLESLEY HOSPITAL   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRICYCLIC ANTIDEPRESSANT AGENT;

BEHAVIOR THERAPY; CHRONICITY; COCHRANE LIBRARY; COGNITIVE THERAPY; DRUG EFFICACY; EMBASE; EVIDENCE BASED MEDICINE; EXPERT SYSTEM; FIBROMYALGIA; FOOD AND DRUG ADMINISTRATION; HUMAN; KINESIOTHERAPY; MEDICAL SOCIETY; MEDLINE; PAIN; PATIENT EDUCATION; PRIORITY JOURNAL; PSYCINFO; REVIEW; SCISEARCH;

EID: 8544239393     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.292.19.2388     Document Type: Review

References (118)

1. Croft P, Rigby AS, Boswell R, et al. The prevalence of chronic widespread pain in the general population. J Rheumatol. 1993;20:710-713.
2. Croft P, Schollum J, Silman A. Population study of tender point counts and pain as evidence of fibromyalgia. BMJ. 1994;309:696-699.
3. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33:160-172.
4. Wolfe F, Cathey MA. Prevalence of primary and secondary fibrositis. J Rheumatol. 1983;10:965-968.
5. Wolfe F, Cathey MA. The epidemiology of tender points. J Rheumatol. 1985;12:1164-1168.
6. Marder WD, Meenan RF, Felson DT, et al. Editorial: the present and future adequacy of rheumatology manpower: a study of health care needs and physician supply. Arthritis Rheum. 1991;34:1209-1217.
7. Crofford U, Clauw DJ. Fibromyalgia: where are we a decade after the American College of Rheumatology classification criteria were developed? Arthritis Rheum. 2002;46:1136-1138.
8. Kroenke K, Harris L. Symptoms research: a fertile field. Ann Intern Med. 2001;134:801-802.
9. Hudson JI, Mangweth B, Pope HC Jr, et al. Family study of affective spectrum disorder. Arch Gen Psychiatry. 2003;60:170-177.
10. Gracely RH, Petzke F, Wolf JM, Clauw DJ. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum. 2002;46:1333-1343.
11. Geisser ME, Casey KL, Brucksch CB, et al. Perception of noxious and innocuous heat stimulation among healthy women and women with fibromyalgia. Pain. 2003;102:243-250.
12. Price DD, Staud R, Robinson ME, et al. Enhanced temporal summation of second pain and its central modulation in fibromyalgia patients. Pain. 2002;99:49-59.
13. Staud R, Cannon RC. Temporal summation of pain from mechanical stimulation of muscle tissue in normal controls and subjects with fibromyalgia syndrome. Pain. 2003;102:87-95.
14. Mountz JM, Bradley LA, Modell JG, et al. Fibromyalgia in women: abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum. 1995;38:926-938.
15. Bradley LA, Mckendree-Smith NL, Alarcon GS, Cianfrini L. Is fibromyalgia a neurologic disease? Curr Pain Headache Rep. 2002;6:106-114.
16. Gracely RH, Grant MA, Giesecke T. Evoked pain measures in fibromyalgia. Best Pract Res Clin Rheumatol. 2003;17:593-609.
17. Russell IJ, Orr MD, Littman B, et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum. 1994;37:1593-1601.
18. Offenbaecher M, Bondy B, Dejonge S, et al. Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum. 1999;42:2482-2488.
19. Gursoy S, Erdal E, Herken H, Madenci E, Alasehirli B. Association of T102C polymorphism of the 5-HT2A receptor gene with psychiatric status in fibromyalgia syndrome. Rheumatol Int. 2001;21:58-61.
20. Gursoy S, Erdal E, Herken H, Madenci E, Alaaehirli B, Erdal N. Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatol Int. 2003;23:104-107.
21. Adler GK, Kinsley Bt, Hurwitz S, et al. Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome. Am J Med. 1999;106:534-543.
22. Crofford U, Pillemer SR, Kalogeras KT, et al. Hypothalamic-pituitary- adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum. 1994;37:1583-1592.
23. Martinez-Lavin M, Hermosillo A, Rosas M, Soto M. Orcadian studies of autonomic nervous balance in patients with fibromyalgia. Arthritis Rheum. 1998;41:1966-1971.
24. Benjamin S, Morris S, Mcbeth J, et al. The association between chronic widespread pain and mental disorder. Arthritis Rheum. 2000;43:561-567.
25. Ehrlich GE. Pain is real; fibromyalgia isn't. J Rheumatol. 2003;30:1666-1667.
26. Goldenberg D, Smith N. Fibromyalgia, rheumatologists, and the medical literature: a shaky alliance. J Rheumatol. 2003;30:151-153.
27. Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: development and validation. J Rheumatol. 1991;18:728-733.
28. Dunkl PR, Taylor AG, Mcconnell GG, et al. Responsiveness of fibromyalgia clinical trial outcome measures. J Rheumatol. 2000;27:2683-2691.
29. Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories IA and II in psychiatric outpatients. J Pers Assess. 1996;67:588-597.
30. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psych. 1960;23:56-62.
31. White KP, Nielson WR, Harth M, Ostbye T, Speechley M. Does the label "fibromyalgia" alter health status, function, and health service utilization? Arthritis Rheum. 2002;47:260-265.
32. Nicassio PM, Radojevic V, Weisman MH, et al. A comparison of behavioral and educational interventions for fibromyalgia. J Rheumatol. 1997;24:2000-2007.
33. Burckhardt CS, Mannerkorpi K, Hedenberg L, Bjelle AA. Randomized, controlled clinical trial of education and physical training for women with fibromyalgia. J Rheumatol. 1994;21:714-720.
34. Burckhardt CS, Bjelle A. Education programmes for fibromyalgia patients: description and evaluation. Baillieres Clin Rheumatol. 1994;8:935-955.
35. Alamo M, Moral RR, Perula de Torres LA. Evaluation of a patient-centered approach in generalized musculoskeletal chronic pain/fibromyalgia patients in primary care. Patient Educ Couns. 2002;48:23-31.
36. Pfeiffer A, Thompson JM, Nelson A, et al. Effects of a 1.5-day multidiscplinary outpatient treatment program for fibromyalgia: a pilot study. Am J Phys Med Rehabil. 2003;82:186-191.
37. Carette S, Mccain GA, Bell DA, Fam AG. Evaluation of amitriptyline in primary fibrositis. Arthritis Rheum. 1986;29:655-659.
38. Goldenberg DL, Felson DT, Dinerman HA. Randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum. 1986;29:1371-1377.
39. Carette S, Bell MJ, Reynolds WJ, et al. Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia: a randomized, double-blind clinical trial. Arthritis Rheum. 1994;37:32-40.
40. Bennett RM, Gatter RA, Campbell SM, et al. A comparison of cyclobenzaprine and placebo in the management of fibrositis. Arthritis Rheum. 1988;31:1535-1542.
41. Tofferi JK, Jackson JL, O'Malley PG. Treatment of fibromyalgia with cyclobenzaprine: a meta-analysis. Arthritis Rheum. 2004;51:9-13.
42. Arnold LM, Keck PE. Antidepressant treatment of fibromyalgia: a meta-analysis and review. Psychosomatics. 2000;41:104-113.
43. O'Malley PG, Balden E, Tomkins G, et al. Treatment of fibromyalgia with antidepressants. J Gen Intern Med. 2000;15:659-666.
44. Wolfe F, Cathey MA, Hawley DJA. Double-blind placebo controlled trial of fluoxetine in fibromyalgia. Scand J Rheumatol. 1994;23:255-259.
45. Arnold LM, Hess EV, Hudson JI, Berno SE, Keck PEA. Randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med. 2002;112:191-197.
46. Goldenberg D, Mayskiy M, Mossey CJ, Ruthazer R, Schmid CA. Randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum. 1996;39:1852-1859.
47. Cantini F, Bellandi F, Niccolo L, et al. Fluoxetine combined with cyclobenzaprine in the treatment of fibromyalgia. Minerva Med. 1994;85:97-100.
48. Celiker R, Cagavi Z. Comparison of amitriptyline and sertraline in the treatment of fibromyalgia syndrome [abstract]. Arthritis Rheum. 2000;43:S332.
49. Zijsltra TR, Barendregt PJ, van de Laar MA. Venlafaxine in fibromyalgia: results of a randomized placebo-controlled, double-blind trial [abstract]. Arthritis Rheum. 2002;46:S105.
50. Dwight MM, Arnold LM, O'Brien H, et al. An open clinical trial of venlafaxine treatment of fibromyalgia. Psychosomatics. 1998;39:14-17.
51. Sayar K, Aksu G, Ak I, Tosum M. Venlafaxine treatment of fibromyalgia. Ann Pharmacother. 2003;37:1561-1565.
52. Gendreau RM, Mease PJ, Rao SR, Kranzler JD, Clauw DJ. Minacipran: a potential new treatment of fibromyalgia [abstract]. Arthritis Rheum. 2003;48:S616.
53. Arnold LM, Lu Y, Crofford LJ, et al. A double-blind multicenter trial comparing duloxetine to placebo in the treatment of fibromyalgia with or without major depressive disorder. Arthritis Rheum. 2004;50:2974-2984.
54. Biasi G, Manca S, Manganelli S, Marcolongo R. Tramadol in the fibromyalgia syndrome: a controlled clinical trial versus placebo. Int J Clin Pharmacol Res. 1998;18:13-19.
55. Russell J, Kamin M, Bennet RM, et al. Efficacy of tramadol in treatment of pain in fibromyalgia. J Clin Rheumatol. 2000;6:250-257.
56. Bennett RM, Kamin M, Karin R, Rosenthal N. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgiapain. Am J Med. 2003;114:537-545.
57. Crofford L, Russell IJ, Mease P, et al. Pregabalin improves pain associated with fibromyalgia syndrome in a multicenter, randomized, placebo-controlled monotherapy trial [abstract]. Arthritis Rheum. 2002;46:S613.
58. Spath M, Stratz T, Neeck G, et al. Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia. Sand J Rheumatol. 2004;33:267-270.
59. Caruso I, Sarzi Puttini P, Cazzola M, Azzolini V. Double-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome. J Int Med Res. 1990;18:201-209.
60. Puttini PS, Caruso I. Primary fibromyalgia syndrome and 5-hydroxy-L-tryptophan: a 90-day open study. J Int Med Res. 1992;20:182-189.
61. Volkmann H, Norregaard J, Jacobsen S, et al. Double-blind, placebo-controlled cross-over study of intravenous S-adenosyl-L-methionine in patients with fibromyalgia. Scand J Rheumatol. 1997;26:206-211.
62. Clark S, Tindall E, Bennett RM. A double blind crossover trial of prednisone versus placebo in the treatment of fibrositis. J Rheumatol. 1985;12:980-983.
63. Bennett RM, Clark SC, Walczyk JA. Randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia. Am J Med. 1998;104:227-231.
64. Bennett RM, Degarmo P, Clark SR. A one year double blind placebo controlled study of guaifenesin in fibromyalgia [abstract]. Arthritis Rheum. 1996;39:S212.
65. McCain GA, Bell DA, Mai FM, et al. A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of primary fibromyalgia. Arthritis Rheum. 1988;31:1135-1141.
66. McCain GA. Role of physical fitness training in the fibrositis/ fibromyalgia syndrome. Am J Med. 1986;81:73-77.
67. Gowans SE, Dehueck A, Voss S, Richardson M. A randomized controlled trial of exercise and education for individuals with fibromyalgia. Arthritis Care Res. 1999;12:120-128.
68. Gowans SE, DeHueck A, Voss S, et al. Effect of a randomized, controlled trial of exercise on mood and physical function in individuals with fibromyalgia. Arthritis Rheum. 2001;45:519-529.
69. Gowans SE, Dehueck A, Abbey S. Measuring exercise-induced mood changes in fibromyalgia. Arthritis Rheum. 2002;47:603-609.
70. Jentoft ES, Kvalvik AG, Mengshoel AM. Effects of pool-based and land-based aerobic exercise on , women with fibromyalgia/chronic widespread muscle pain. Arthritis Rheum. 2001;45:42-47.
71. Schachter CL, Busch AJ, Peloso PM, Sheppard MS. Effects of short versus long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Phys Ther. 2003;83:340-358.
72. Jones KD, Burckhardt C, Clark SR, Bennett RM, Potempa KM. A randomized controlled trial of muscle strengthening versus flexibility training in fibromyalgia. J Rheumatol. 2002;29:1041-1048.
73. Mannerkorpi K, Nyberg B, Ekdahl C. Pool exercise combined with an education program for patients with fibromyalgia syndrome: a prospective, randomized study. J Rheumatol. 2000;27:2473-2481.
74. Mannerkorpi K, Ahlmen M, Ekdahl C. Six- and 24-month follow-up of pool exercise therapy and education for patients with fibromyalgia. Scand J Rheumatol. 2002;31:306-310.
75. Busch A, Schachter CL, Peloso PM, Bombardier C. Exercise for treating fibromyalgia syndrome. Cochrane Database Syst Rev. 2003;3:CD003786.
76. Buckelew SP, Conway R, Parker J, et al. Biofeedback/relaxation training and exercise interventions for fibromyalgia. Arthritis Care Res. 1998;11:196-209.
77. Mengshoel AM, Komnæs HB, Fqrre Æ. The effects of 20 weeks of physical fitness training in female patients with fibromyalgia. Clin Exp Rheumatol. 1992;10:345-349.
78. Wigers SH, Stiles TC, Vogal PA. Effects of aerobic exercise versus stress management treatment in fibromyalgia. Scand J Rheumatol. 1996;25:77-86.
79. Hakkinen A, Hakkinen K, Alen M. Strength training induced adaptations in neuromuscular function of premenopausal women with fibromyalgia. Ann Rheum Dis. 2001;60:21-26.
80. Martin L, Nutting A, Macintosh BR, Edworthy SM, Butterwick D, Cook J. An exercise program in the treatment of fibromyalgia. J Rheumatol. 1996;23:1050-1053.
81. Mannerkorpi K, Iversen MD. Physical exercise in fibromyalgia and related syndromes. Best Prad Res Clin Rheumatol. 2003;17:629-647.
82. Valim V, Oliveira L, Suda A, et al. Aerobic fitness effects in fibromyalgia. J Rheumatol. 2003;30:1060-1069.
83. Nielson WR, Walker C, Mccain GA. Cognitive behavioral treatment of fibromyalgia syndrome: preliminary findings. J Rheumatol. 1992;19:98-103.
84. White KP, Nielson WR, Cognitive behavioral treatment of fibromyalgia syndrome: a follow-up assessement. J Rheumatol. 1995;22:717-721.
85. Hadhazy V, Ezzo JM, Berman BM, Creamer P, Bauseil B. Mind and body therapy for fibromyalgia: a systematic review. J Rheumatol. 2000;27:2911-2918.
86. Creamer P, Singh BB, Hochberg MC, Berman BM. Sustained improvement produced by nonpharmacologic intervention in fibromyalgia: results of a pilot study. Arthritis Care Res. 2000;13:198-204.
87. Singh BB, Berman BM, Creamer P. A pilot study of cognitive behavioral therapy in fibromyalgia. Altern Ther Health Med. 1998;4:67-70.
88. Kaplan KH, Goldenberg DL, Galvin-Nadeau M. The impact of a meditation-based stress reduction program on fibromyalgia. Gen Hosp Psychiatry. 1993;15:284-289.
89. De Gier M, Peters ML, Vlaeyan JW. Fear of pain, physical performance, and attentional processes in patients with fibromyalgia. Pain. 2003;104:121-130.
90. Williams DA. Psychological and behavioural therapies in fibromyalgia and related syndromes. Best Pract Res Clin Rheumatol. 2003;17:649-665.
91. Rossy LA, Buckelew SP, Dorr N, et al. A meta-analysis of fibromyalgia treatment interventions. Ann Behav Med. 1999;21:180-191.
92. Keel PA Bodoky C, Gerhard U, Muller W. Comparison of integrated group therapy and group relaxation training for fibromyalgia. Clin J Pain. 1998;14:232-238.
93. King SJ, Wessel J, Bhambhani Y, Sholter D, Maksymowych W. The effects of exercise and education, individually or combined, in women with fibromyalgia. J Rheumatol. 2002;29:2620-2627.
94. Mengshoel AM, Forseth KO, Haugen M, et al. Multidisciplinary approach to fibromyalgia: a pilot study. Clin Rheumatol. 1995;14:165-170.
95. Bennett RM. Multidisciplinary group programs to treat fibromyalgia patients. Rheum Dis Clin North Am. 1996;22:351-367.
96. Turk DC, Okifuji A, Sinclair JD, Starz TW. Differential responses by psychosocial subgroups of fibromyalgia syndrome patients to an interdisciplanary treatment. Arthritis Care Res. 1998;11:397-404.
97. Bailey A, Starr L, Alderson M, Moreland J. A comparative evaluation of a fibromyalgia rehabilitation program. Arthritis Care Res. 1999;12:336-340.
98. Fors EA, Sexton H, Gotestam KG. The effect of guided imagery and amitriptyline on daily fibromyalgia pain. J Psychiatr Res. 2002;36:179-187.
99. Haanen HC, Hoenderdos HT, van Romunde LK, et al. Controlled trial of hypnotherapy in the treatment of refractory fibromyalgia. J Rheumatol. 1991;18:72-75.
100. Wik C, Fischer H, Bragee B, Finer B, Fredrikson M. Functional anatomy of hypnotic analgesia: a PET study of patients with fibromyalgia. Eur J Pain. 1999;3:7-12.
101. Ferraccioli G, Ghirelli L, Scita F, et al. EMG-biofeedback training in fibromyalgia syndrome. J Rheumatol. 1987;14:820-825.
102. Günther V, Mur E, Kinigadner U, Miller C. Fibromyalgia: the effect of relaxation and hydrogalvanic bath therapy on the subjective pain experience. Clin Rheumatol. 1994;13:573-578.
103. Sarnoch H, Adler F, Scholz OB. Relevance of muscular sentivity, muscular activity, and cognitive variables for pain reduction associated with EMG biofeedback in fibromyalgia. Percept Mot Skills. 1997;84:1043-1050.
104. Berman BM, Ezzo J, Hadhazy V, Swyers JP. Is acupuncture effective in the treatment of fibromyalgia? J Fam Pract. 1999;48:213-218.
105. Deluze C, Bosia L, Zirbs A, Chantraine A, Vischer TL. Electroacupuncture in fibromyalgia: results of a controlled trial. BMJ. 1992;305:1249-1252.
106. Harris RE, Tian X, Cupps TR, et al. The treatment of fibromyalgia with acupuncture [abstract]. Arthritis Rheum. 2003;48:S692.
107. Blunt KL, Rajwani MH, Guerriero RC. The effectiveness of chiropractic management of fibromyalgia patients. J Manipulative Physiol Ther. 1997;20:389-399.
108. Brattberg G. Connective tissue massage in the treatment of fibromyalgia. Eur J Pain. 1999;3:235-244.
109. Gambert RG, Shores JH, Russo DP, et al. Osteopathic manipulative treatment in conjunction with medication relieves pain associated with fibromyalgia syndrome. J Am Osteopath Assoc. 2002;102:321-325.
110. Almeida TF, Roizenblatt S, Benedito-Silva AA, Tufik S. The effect of combined therapy (ultrasound and interferential current) on pain and sleep in fibromyalgia. Pain. 2003;104:665-672.
111. Buskila D, Abu-Shakra M, Neumann L, et al. Balneotherapy for fibromyalgia at the Dead Sea. Rheumatal Int. 2001;20:105-108.
112. Sukenik S, Flusser D, Abu-Shakra M. The role of spa therapy in various rheumatic diseases. Rheum Dis Clin North Am. 1999;25:883-891.
113. Turk DC, Okifuji A, Sinclair JD, Starz TW. Pain, disability, and physical functioning in subgroups of patients with fibromyalgia. J Rheumatol. 1996;23:1255-1262.
114. Jensen MP, Nielson WR, Turner JA, et al. Readiness to self-manage pain is associated with coping and with psychological and physical functioning among patients with chronic pain. Pain. 2003;104:529-537.
115. Giesecke T, Williams DA, Harris RE, et al. Sub-grouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arthritis Rheum. 2003;48:2916-2922.
116. Isomeri R, Mikkelsson M, Latikka P, Kammonen K. Effects of amitriptyline and cardiovascular fitness training on pain in patients with primary fibromyalgia. J Musculoskel Pain. 1993;1:253-260.
117. Guyatt G, Sackett D, Taylor DW, et al. Determining optimal therapy: randomized trials in individual patients. N Engl J Med. 1986;314:889-892.
118. Jaeschke R, Adachi J, Guyatt G, Keller J, Wong B. Clinical usefulness of amitriptyline in fibromyalgia. J Rheumatol. 1991;18:447-451.